Selected nontransplant studies with radioimmunoconjugates in AML
BM indicates bone marrow; CMML, chronic myelomonocytic leukemia; CRp, CR with incomplete platelet count recovery; DLT, dose-limiting toxicity; ND, newly diagnosed; PB, peripheral blood; R/R, relapsed/refractory.
Sign In or Create an Account